News

Novel, oral candidate with first-in-class potential progresses to regulatory non-clinical studies to support a Clinical Trial ...
Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA).
Understanding the subtypes of juvenile idiopathic arthritis can help adult and pediatric rheumatologists manage patients ...
Home massagers aren’t just for your back or feet. If you’re dealing with arthritis or carpal tunnel, or just use your hands a ...
India Bolton, a psoriatic arthritis patient, sits down with Health to discuss her experiences with the disease, what she ...
Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...
Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...
Teva Pharmaceuticals and Alvotech have announced that the US Food and Drug Administration (FDA) has approved the Selarsdi ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has reported that the FDA has approved the biosimilar treatment ...
Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...
A shared neuroimmune pathway involving CRH, mast cells, and Th17 cells may underlie the link between psoriatic arthritis and ...
Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...